# Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

> **NCT04668001** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 19 (actual)

## Conditions studied

- Down Syndrome

## Interventions

- **DEVICE:** Near-Infrared Transcranial Photobiomodulation
- **DEVICE:** Sham Transcranial Photobiomodulation

## Key facts

- **NCT ID:** NCT04668001
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-19
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-09-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04668001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04668001, "Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04668001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*